Where leprosy still lives
Leprosy affected 214,000-300,000 people per year globally between 2005 and 2014. It remains as a public health problem, particularly in the poorest communities of developing countries, such as India, Brazil and Indonesia. Globally, these three countries accounted for 81% of all registered new leprosy cases in 2014. Leprosy is a chronic infectious disease caused by the Mycobacterium leprae. It affects mainly the skin and peripheral nerves, which can lead to severe physical disabilities and deformities if not diagnosed and appropriately treated in its early stages. Evidences suggest that M. leprae can spread from person to person through nasal and oral droplets and this is considered to be the main route of transmission, especially among household contacts and neighbours of an untreated patient. Early diagnosis and complete treatment with antibiotics remain the key strategies for reducing disease burden due to leprosy.
Spatial epidemiology describes where the diseases and their risk factors are located in global, national, regional or local levels. It has become an increasingly important tool in public health to study transmission dynamics of several diseases and for building interventions targeting high-risk areas. Therefore, the main objective of this study was to describe and evaluate a targeted screening strategy for the early diagnosis of leprosy cases, involving school-based active clinical surveillance in high risk areas. Additionally, we followed subjects with or without immunological evidence of subclinical infection (as defined by the presence or absence of antibodies against the Mycobacterium leprae).
We selected two elementary public schools located in areas most at risk (cluster of leprosy or hyperendemic census tract), determined by spatial epidemiology, to clinically evaluate their students in a hyperendemic municipality of the Brazilian Amazon region. We also followed anti-PGL-I seropositive and seronegative individuals and households for 2 years to compare the incidence of leprosy in both groups.
Leprosy was detected in 11 (8.2 %) of 134 school children in high risk areas. The difference in the prevalence was statistically significant compared to our previous findings in randomly selected schools (63/1592; 3.9 %). The 2-year follow-up results showed that 22.3 and 9.4 % of seropositive and seronegative individuals, respectively, developed leprosy. The odds of developing overt disease in seropositive people were 2.7 times that of negative people, indicating that a follow-up of 10 seropositives has a >90% probability to detect at least one new case in 2 years. The odds of clinical leprosy were also higher in “positive houses” compared to “negative houses”, indicating that a follow-up of ten people living in households with at least one seropositive dweller have an 85% probability to detect at least one new case in 2 years.
Targeted screening involving school-based surveillance planned using results obtained by spatial analysis and targeted household and individual continuous surveillance based on serologic data significantly increases the likelihood of early detection of new leprosy cases. Based on our findings, we strongly believe that if largescale school children surveys are performed in specific spatial clusters of leprosy in each hyperendemic municipality with well-trained personnel, the detection rate would be much higher. We advocate such an approach both for public health reasons and because it will be more cost-effective than what has been conducted in endemic countries.
Josafá Gonçalves Barreto
Adjunct Professor at Federal University of Pará
Spatial epidemiology and serologic cohorts increase the early detection of leprosy.
Barreto JG, Bisanzio D, Frade MA, Moraes TM, Gobbo AR, de Souza Guimarães L, da Silva MB, Vazquez-Prokopec GM, Spencer JS, Kitron U, Salgado CG.
BMC Infect Dis. 2015 Nov 16